JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264732

Human APLNR (APJ Receptor) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

APLNR KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 13 bp deletion in exon 1 and 1 bp deletion in exon 1.

View Alternative Names

AGTR L1, APJ (apelin) receptor, APJ receptor, APJR, APJ_HUMAN, APLNR, Angiotensin II receptor like 1, Angiotensin receptor-like 1, Apelin receptor, B78, FLJ90771, G-protein coupled receptor APJ, G-protein coupled receptor HG11, GPCR34, HG 11, HG11 orphan receptor, MGC45246, msr/apj

2 Images
Sanger Sequencing - Human APLNR (APJ Receptor) knockout HeLa cell line (AB264732)
  • Sanger seq

Unknown

Sanger Sequencing - Human APLNR (APJ Receptor) knockout HeLa cell line (AB264732)

Allele-2 : 1 bp deletion in exon 1.

Sanger Sequencing - Human APLNR (APJ Receptor) knockout HeLa cell line (AB264732)
  • Sanger seq

Unknown

Sanger Sequencing - Human APLNR (APJ Receptor) knockout HeLa cell line (AB264732)

Allele-1 : 13 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 13 bp deletion in exon 1 and 1 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264732-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264732 Human APLNR (APJ Receptor) knockout HeLa cell line", "number":"AB264732-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264732-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264732 Human APLNR (APJ Receptor) knockout HeLa cell line", "number":"AB264732-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
APLNR
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The APJ Receptor also known as the Apelin Receptor (APLNR) is a G protein-coupled receptor with a molecular mass of approximately 42 kDa. You find APJ Receptor highly expressed in tissues like the brain heart and lungs. It acts as a receptor for the peptides called apelin and elabela playing a critical role in signaling processes across various tissues. The receptor demonstrates complex mechanical actions by coupling with G proteins to inhibit adenylate cyclase activity and regulate other intracellular signaling pathways.
Biological function summary

The APJ Receptor influences cardiovascular function fluid homeostasis and energy metabolism. It does not form a part of a larger receptor complex but collaborates closely with other proteins within cellular networks. APJ Receptor engagement by apelin or elabela modulates blood pressure cardiac contractility and fluid balance underlying its important role in cardiovascular and renal systems. Therefore this receptor contributes significantly to maintaining physiological homeostasis.

Pathways

The APJ Receptor is integral to the Apelin signaling pathway known to influence cardiac function and embryonic development. It interacts with proteins such as the angiotensin receptor which also participates in regulation of blood pressure. Additionally APJ Receptor involvement in the PI3K-Akt signaling pathway affects cell survival and growth allowing it to intersect with pathways involved in various physiological processes.

APJ Receptor has connections to conditions like heart failure and pulmonary hypertension. Altered APJ Receptor function contributes to these diseases through its effect on cardiac and vascular systems. Moreover interactions between APJ Receptor and proteins such as endothelin receptors highlight its role in the progression of pulmonary hypertension highlighting the receptor as a potential therapeutic target in cardiovascular disease management.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com